Background: A mild restraint stressor suppressed an increase in the levels of Th2-dependent cytokines and IgE, thereby reducing the symptoms of pollinosis. In the present study, to clarify the mechanism of action of adrenocorticotropic hormone (ACTH) in improving the symptoms of pollinosis, we studied the effects of ACTH on the plasma level of histamine, mast cell number in nasal-associated lymphoid tissue (NALT) and the T cell differentiation in splenocytes. Methods: The role of ACTH in the development of pollen antigen-induced pollinosis was studied in mice. Allergic symptoms and parameters were measured on day 17 after sensitization. To investigate the effects of ACTH on T cell differentiation, we stimulated splenocytes obtained from control mice with ACTH and CD3/CD28 in vitro, and measured the cytokine production in the culture supernatant. Results: The plasma levels of IL-10, IgE and histamine and mast cell number in NALT were increased in the sensitized animals in association with a concomitant increase in the incidence of sneezing and nasal rubbing. The intraperitoneal administration of ACTH decreased the IL-10, IgE and histamine levels in the plasma and mast cell number in NALT, while increasing the IFN-γ level and suppressing the incidence of nasal rubbing. Furthermore, the production of IFN-γ increased, while the IL-4 level was suppressed after 2 days in culture. Conclusions: The present findings showed that ACTH directly affects T cell differentiation and promotes Th1-type reactions. The regulation of the Th1/Th2 balance by ACTH may result in a decrease in the pathological features of pollinosis.

1.
Yasueda H, Yui Y, Shimizu T, Shida T: Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983;71(1 Pt 1):77-86.
2.
Kaneko Y, et al: Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis. Int Arch Allergy Immunol 2005;136:365-371.
3.
Okuda M: Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003;91:288-296.
4.
Morgenstern V, et al: Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med 2008;177:1331-1337.
5.
Nakamura K, et al: Association of farming with the development of cedar pollinosis in Japanese adults. Ann Epidemiol 2010;20:804-810.
6.
von Mutius E, et al: Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998;351:862-866.
7.
Lau S, et al: High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol 1989;84(5 Pt 1):718-725.
8.
Hashimoto M, et al: Role of the hypothalamo-pituitary-adrenal axis in the modulation of pollinosis induced by pollen antigens. Allergol Int 2010;59:201-206.
9.
Catania A, et al: Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004;56:1-29.
10.
Catania A, Lonati C, Sordi A, Carlin A, Leonardi P, Gatti S: The melanocortin system in control of inflammation. Sci World J 2010;10:1840-1853.
11.
Benjamins JA, et al: ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro. Glia 2013;61:1206-1217.
12.
Arnason BG, et al: Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler 2013;19:130-136.
13.
Ross AP, et al: Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone. Front Neurol 2013;4:21.
14.
Aebischer I, et al: Neuropeptides accentuate interleukin-4 induced human immunoglobuline E synthesis in vitro. Exp Dermatol 1996;5:38-44.
15.
Johnson EW, Hughes TK Jr, Smith EM: ACTH enhancement of T-lymphocyte cytotoxic responses. Cell Mol Neurobiol 2005;25:743-757.
16.
Johnson HM, Torres BA, Smith EM, Dion LD, Blalock JE: Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol 1984;132:246-250.
17.
Auriemma M, Brzoska T, Klenner L, Kupas V, Goerge T, Voskort M, Zhao Z, Sparwasser T, Luger TA, Loser K: α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation. J Invest Dermatol 2012;132:1814-1824.
18.
Zwermann O, Schulte DM, Reincke M, Beuschlein F: ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo. Eur J Endocrinol 2005;153:435-444.
19.
Takubo M, Inoue T, Jiang S, Tsumuro T, Ueda Y, Yatsuzuka R, Segawa S, Watari J, Kamei C: Effects of hop extracts on nasal rubbing and sneezing in BALB/c mice. Biol Pharm Bull 2006;29:689-692.
20.
Heritage PL, et al: Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am J Respir Crit Care Med 1997;156(4 Pt 1):1256-1262.
21.
Asanuma H, et al: Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 1997;202:123-131.
22.
Kim DY, et al: Implications of nasopharynx-associated lymphoid tissue (NALT) in the development of allergic responses in an allergic rhinitis mouse model. Allergy 2012;67:502-509.
23.
Ohmichi Y, et al: Essential role of peripheral node addressin in lymphocyte homing to nasal-associated lymphoid tissues and allergic immune responses. J Exp Med 2011;208:1015-1025.
24.
Borish LC, Steinke JW: 2. Cytokines and chemokines. J Allergy Clin Immunol 2003;111(2 suppl):S460-S475.
25.
Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997;77:1033-1079.
26.
Barrett KE: Cytokines: sources, receptors and signalling. Baillieres Clin Gastroenterol 1996;10:1-15.
27.
Fujiwara D, et al: The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 2004;135:205-215.
28.
Pene J, et al: IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α and prostaglandin E2. Proc Natl Acad Sci U S A 1988;85:6880-6884.
29.
Prussin C, Metcalfe DD: 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003;111(2 suppl):S486-S494.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.